[ad_1]
This authorization is the latest move in the United States to broadly expand vaccine enhancement activities.
The U.S. Food and Drug Administration (FDA) has approved a booster for people vaccinated with Moderna and Johnson & Johnson coronavirus vaccines, while authorizing anyone who is eligible for additional doses to be vaccinated with a brand different from the one they used when they were initially vaccinated.
The approval announced on Wednesday is a big step towards President Joe Biden’s substantial expansion of his booster campaign goals.Last month, the United States started manage Provide additional doses of Pfizer BioNTech vaccine for people 65 years and older, people at risk of serious illness, and people exposed to the virus at work.
Approval of Moderna and Johnson & Johnson vaccines will now be transferred to the Centers for Disease Control and Prevention (CDC), which will consult a panel of experts on Thursday and then finalize who and when to receive official recommendations for boosters.
“Today, currently available data indicate that the immunity of certain fully vaccinated populations is weakening,” FDA Acting Commissioner Janet Woodcock told reporters. “The availability of these authorized boosters is important for the continued prevention of COVID-19 disease.”
The decision of Moderna Booster is basically in line with the FDA’s ruling that high-risk populations are eligible for Pfizer vaccine, which is manufactured using the same technology.
At the same time, the agency recommends that all people who have received a single injection of Johnson & Johnson receive a booster, because its protective effect has been lower than that of its two-injected competitors.
The FDA approves the use of any authorized vaccine as a booster. Regardless of which vaccine people receive first, it is expected to accelerate the government’s campaign, especially in nursing homes and other institutional environments. Over time, residents receive different injections. .
In August, the Biden administration announced a plan to provide comprehensive support to all American adults, but outside experts have repeatedly opposed such comprehensive efforts.
The World Health Organization calls on rich countries to tackle global inequality before they use boosters extensively.
At the same time, the US government continues to emphasize that its priority is to vaccinate the country’s approximately 66 million eligible people who have not been vaccinated.
[ad_2]
Source link